Evaluation of Tp-e Interval and Tp-e/QT Ratio in Dermatomyositis and Analysis of Their Relationship With Inflammation
Condition: Dermatomyositis Myocardial Repolarization Tp-e Interval Tp-e/QT Inflammation Intervention: Sponsor: The Third People's Hospital of Hangzhou Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
Evaluation of Tp-e Interval and Tp-e/QT Ratio in Dermatomyositis and Analysis of Their Relationship With Inflammation
Conditions: Dermatomyositis; Myocardial Repolarization; Inflammation Intervention: Sponsor: The Third People's Hospital of Hangzhou Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
Evaluation of Tp-e Interval and Tp-e/QT Ratio in Dermatomyositis and Analysis of Their Relationship With Inflammation
Condition: Dermatomyositis Myocardial Repolarization Tp-e Interval Tp-e/QT Inflammation Intervention: Sponsor: The Third People's Hospital of Hangzhou Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
Evaluation of Tp-e Interval and Tp-e/QT Ratio in Dermatomyositis and Analysis of Their Relationship With Inflammation
Conditions: Dermatomyositis; Myocardial Repolarization; Inflammation Intervention: Sponsor: The Third People's Hospital of Hangzhou Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
Safety and Preliminary Clinical Activity of Itolizumab in Dermatomyositis
Condition: Dermatomyositis, Adult Type Intervention: Drug: Itolizumab Sponsor: Biotech Pharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
